House Bill 275
116th Congress(2019-2020)
Medicare Prescription Drug Price Negotiation Act of 2019
Introduced
Introduced in House on Jan 8, 2019
Origin Chamber
House
Type
Bill
Bill
The primary form of legislative measure used to propose law. Depending on the chamber of origin, bills begin with a designation of either H.R. or S. Joint resolution is another form of legislative measure used to propose law.
Bill Number
275
Congress
116
Policy Area
Health
Health
Primary focus of measure is science or practice of the diagnosis, treatment, and prevention of disease; health services administration and funding, including such programs as Medicare and Medicaid; health personnel and medical education; drug use and safety; health care coverage and insurance; health facilities. Measures concerning controlled substances and drug trafficking may fall under Crime and Law Enforcement policy area.
No House votes have been held for this bill.
Summary
Medicare Prescription Drug Price Negotiation Act of 2019
This bill requires the Centers for Medicare & Medicaid Services (CMS) to negotiate with pharmaceutical companies regarding prices for drugs covered under the Medicare prescription drug benefit. Current law prohibits the CMS from doing so.
January 8, 2019
Sort by most recent
09/25/2019
Subcommittee Hearings Held.
01/25/2019
Referred to the Subcommittee on Health.
01/08/2019
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
01/08/2019
Referred to the Subcommittee on Health.
01/08/2019
Introduced in House
Public Record
Record Updated
Nov 1, 2022 1:49:24 PM